140 related articles for article (PubMed ID: 7696314)
21. Glycosylation at Asn-184 inhibits the conversion of single-chain to two-chain tissue-type plasminogen activator by plasmin.
Wittwer AJ; Howard SC
Biochemistry; 1990 May; 29(17):4175-80. PubMed ID: 2141793
[TBL] [Abstract][Full Text] [Related]
22. Requirement of zymogen modification for activation of porcine plasminogen.
Machovich R; Litwiller RD; Owen WG
Biochemistry; 1992 Nov; 31(46):11558-61. PubMed ID: 1445889
[TBL] [Abstract][Full Text] [Related]
23. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate.
Kulisek ES; Holm SE; Johnston KH
Anal Biochem; 1989 Feb; 177(1):78-84. PubMed ID: 2525884
[TBL] [Abstract][Full Text] [Related]
24. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
[TBL] [Abstract][Full Text] [Related]
25. The effect of polymerised fibrin on the catalytic activities of one-chain tissue-type plasminogen activator as revealed by an analogue resistant to plasmin cleavage.
Petersen LC; Johannessen M; Foster D; Kumar A; Mulvihill E
Biochim Biophys Acta; 1988 Feb; 952(3):245-54. PubMed ID: 2962643
[TBL] [Abstract][Full Text] [Related]
26. Myosin as cofactor and substrate in fibrinolysis.
Machovich R; Ajtai K; Kolev K; Owen WG
FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
[TBL] [Abstract][Full Text] [Related]
27. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis.
Bergum PW; Gardell SJ
J Biol Chem; 1992 Sep; 267(25):17726-31. PubMed ID: 1387641
[TBL] [Abstract][Full Text] [Related]
28. Oxidative inactivation of plasmin and other serine proteases by copper and ascorbate.
Lind SE; McDonagh JR; Smith CJ
Blood; 1993 Sep; 82(5):1522-31. PubMed ID: 8364203
[TBL] [Abstract][Full Text] [Related]
29. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
Petersen LC; Suenson E
Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.
Chmielewska J; RĂ„nby M; Wiman B
Biochem J; 1988 Apr; 251(2):327-32. PubMed ID: 3135797
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of plasmin activity by oleic acid.
Higazi AA; Finci-Yeheskel Z; Samara AA; Aziza R; Mayer M
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):863-6. PubMed ID: 1532491
[TBL] [Abstract][Full Text] [Related]
32. Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
Urano T; deSerrano VS; Urano S; Castellino FJ
Arch Biochem Biophys; 1989 Apr; 270(1):356-62. PubMed ID: 2494944
[TBL] [Abstract][Full Text] [Related]
33. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
Gurewich V; Pannell R; Broeze RJ; Mao J
J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
[TBL] [Abstract][Full Text] [Related]
35. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
Karlan BY; Clark AS; Littlefield BA
Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of plasmin activity by aspirin.
Milwidsky A; Finci-Yeheskel Z; Mayer M
Thromb Haemost; 1991 Apr; 65(4):389-93. PubMed ID: 1829277
[TBL] [Abstract][Full Text] [Related]
37. Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).
Pannell R; Gurewich V
Blood; 1987 Jan; 69(1):22-6. PubMed ID: 3790724
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Zhang X; Chaudhry A; Chintala SK
Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of fibrinolytic system by liquoid (polyanetholesulfonate). A contributing factor in the liquoid-induced renal cortical necrosis.
Gilboa N; Ryan TJ; MacColl R
Haemostasis; 1987; 17(3):162-70. PubMed ID: 3038710
[TBL] [Abstract][Full Text] [Related]
40. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
Ts'ao C; Galluzzo TS
Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]